This post was originally published on this site
IDEXX Labs announced earnings per share of $1.58 on revenue of $860.55M. Analysts polled by Investing.com anticipated EPS of $1.65 on revenue of $864.61M.
IDEXX Labs shares are down 39.54% from the beginning of the year, still down 43.65% from its 52 week high of $706.51 set on August 4, 2021. They are under-performing the Nasdaq which is down 20.94% from the start of the year.
IDEXX Labs’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
